13 July 2016Americas

Nichi-Iko to acquire Sagent for $736m

Nichi-Iko Pharmaceutical, a Tokyo-based drugs company, will acquire Illinois-based Sagent Pharmaceuticals for $736 million in cash.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk